Mtor inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Cells, Cultured Cell Line HCT116 Cells Tumor Cells, Cultured

Organisms7

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred C57BL Mice, Knockout Mice, Inbred NOD Mice, Inbred BALB C

Diseases23

Tuberous Sclerosis Angiomyolipoma Kidney Neoplasms Carcinoma, Renal Cell Neoplasms Polycystic Kidney Diseases Lymphangioleiomyomatosis Disease Models, Animal Neuroendocrine Tumors Pancreatic Neoplasms Breast Neoplasms Lung Neoplasms Lymphoma, Mantle-Cell Endometrial Neoplasms Neovascularization, Pathologic Glioblastoma Cell Transformation, Neoplastic Disease Progression Prostatic Neoplasms Glioma Multiple Myeloma Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung

Chemicals and Drugs70

TOR Serine-Threonine Kinases Sirolimus Ribosomal Protein S6 Kinases, 70-kDa Protein Kinases Protein Kinase Inhibitors Proto-Oncogene Proteins c-akt Phosphatidylinositol 3-Kinases Quinolines Antibiotics, Antineoplastic Phosphatidylinositol 3-Kinase Multiprotein Complexes Ribosomal Protein S6 Antineoplastic Agents Immunosuppressive Agents PTEN Phosphohydrolase Furans Imidazoles Morpholines Ribosomal Protein S6 Kinases Protein-Serine-Threonine Kinases Oncogene Protein v-akt Naphthyridines Pyrimidines Intracellular Signaling Peptides and Proteins Heterocyclic Compounds, 3-Ring Chromones Tacrolimus Binding Protein 1A Eukaryotic Initiation Factor-4E Purines Enzyme Inhibitors Indoles Pyridines Tumor Suppressor Proteins Phosphoproteins Extracellular Signal-Regulated MAP Kinases Adaptor Proteins, Signal Transducing Carrier Proteins Proteins Phosphotransferases (Alcohol Group Acceptor)Benzenesulfonates Phenylurea Compounds Receptor, IGF Type 1 Niacinamide ras Proteins Transcription Factors Proto-Oncogene Proteins B-raf RNA, Small Interfering AMP-Activated Protein Kinases Sulfonamides Angiogenesis Inhibitors Radiation-Sensitizing Agents Androstadienes Glycogen Synthase Kinase 3 Calcineurin Nitriles Proto-Oncogene Proteins Mitogen-Activated Protein Kinase Kinases Vascular Endothelial Growth Factor A Receptor, Epidermal Growth Factor Pyrroles Monomeric GTP-Binding Proteins RNA, Messenger Quinazolines Tumor Markers, Biological Piperazines Ribosomal Protein S6 Kinases, 90-kDa Receptor, erbB-2 Glucose Antibodies, Monoclonal, Humanized Antibodies, Monoclonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment25

Xenograft Model Antitumor Assays Molecular Targeted Therapy Tumor Burden Blotting, Western Antineoplastic Combined Chemotherapy Protocols Disease Models, Animal Clinical Trials as Topic Inhibitory Concentration 50 Treatment Outcome Models, Biological Drug Evaluation, Preclinical Transplantation, Heterologous Immunohistochemistry Kidney Transplantation Drug Screening Assays, Antitumor Immunoenzyme Techniques Real-Time Polymerase Chain Reaction Immunoblotting Flow Cytometry Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Drug Administration Schedule Administration, Oral Gene Expression Profiling Transfection

Phenomena and Processes26

Signal Transduction Cell Proliferation Phosphorylation Drug Synergism Autophagy Drug Resistance, Neoplasm Apoptosis Cell Survival Cell Growth Processes Enzyme Activation Cell Cycle Protein Biosynthesis Mutation Cell Cycle Checkpoints Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Inhibitory Concentration 50 Down-Regulation MAP Kinase Signaling System Gene Expression Regulation Time Factors Cell Death Graft Rejection Cell Movement Cell Division Transfection

Disciplines and Occupations1

Immunohistochemistry

Health Care2

Clinical Trials as Topic Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Health Care

TOR Serine-Threonine Kinases Sirolimus Ribosomal Protein S6 Kinases, 70-kDa Protein Kinases Protein Kinase Inhibitors Proto-Oncogene Proteins c-akt Signal Transduction Phosphatidylinositol 3-Kinases Quinolines Antibiotics, Antineoplastic Cell Line, Tumor Phosphatidylinositol 3-Kinase Multiprotein Complexes Ribosomal Protein S6 Tuberous Sclerosis Cell Proliferation Antineoplastic Agents Immunosuppressive Agents Xenograft Model Antitumor Assays PTEN Phosphohydrolase Furans Imidazoles Phosphorylation Drug Synergism Molecular Targeted Therapy Morpholines Autophagy Ribosomal Protein S6 Kinases Protein-Serine-Threonine Kinases Oncogene Protein v-akt Drug Resistance, Neoplasm Naphthyridines Pyrimidines Intracellular Signaling Peptides and Proteins Angiomyolipoma Apoptosis Kidney Neoplasms Mice, Nude Heterocyclic Compounds, 3-Ring Chromones Carcinoma, Renal Cell Neoplasms Tumor Burden Tacrolimus Binding Protein 1A Eukaryotic Initiation Factor-4E Cell Survival Purines Enzyme Inhibitors Indoles Blotting, Western Pyridines Tumor Suppressor Proteins Mice, SCID Phosphoproteins Extracellular Signal-Regulated MAP Kinases Adaptor Proteins, Signal Transducing Antineoplastic Combined Chemotherapy Protocols Polycystic Kidney Diseases Lymphangioleiomyomatosis Carrier Proteins Proteins Phosphotransferases (Alcohol Group Acceptor)Cell Growth Processes Benzenesulfonates Enzyme Activation Phenylurea Compounds Disease Models, Animal Cell Cycle Receptor, IGF Type 1 Niacinamide ras Proteins Neuroendocrine Tumors Transcription Factors Protein Biosynthesis Mutation Proto-Oncogene Proteins B-raf Pancreatic Neoplasms RNA, Small Interfering Cells, Cultured Cell Cycle Checkpoints Clinical Trials as Topic AMP-Activated Protein Kinases Gene Expression Regulation, Neoplastic Sulfonamides Angiogenesis Inhibitors Radiation-Sensitizing Agents Dose-Response Relationship, Drug Androstadienes Breast Neoplasms Cell Line Inhibitory Concentration 50 Treatment Outcome Models, Biological Drug Evaluation, Preclinical Down-Regulation MAP Kinase Signaling System Glycogen Synthase Kinase 3 Lung Neoplasms Lymphoma, Mantle-Cell Calcineurin

No FAQ available that match "mtor inhibitors"